ZA937155B - Piperidine derivatives their preparation and theirapplication in therapeutics - Google Patents

Piperidine derivatives their preparation and theirapplication in therapeutics

Info

Publication number
ZA937155B
ZA937155B ZA937155A ZA937155A ZA937155B ZA 937155 B ZA937155 B ZA 937155B ZA 937155 A ZA937155 A ZA 937155A ZA 937155 A ZA937155 A ZA 937155A ZA 937155 B ZA937155 B ZA 937155B
Authority
ZA
South Africa
Prior art keywords
theirapplication
therapeutics
preparation
piperidine derivatives
piperidine
Prior art date
Application number
ZA937155A
Other languages
English (en)
Inventor
Samir Jegham
Gerard Defosse
Thomas Purcell
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of ZA937155B publication Critical patent/ZA937155B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
ZA937155A 1992-09-28 1993-09-27 Piperidine derivatives their preparation and theirapplication in therapeutics ZA937155B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9211550A FR2696176B1 (fr) 1992-09-28 1992-09-28 Dérivés de pipéridine, leur préparation et leur application en thérapeutique.

Publications (1)

Publication Number Publication Date
ZA937155B true ZA937155B (en) 1994-05-23

Family

ID=9433966

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA937155A ZA937155B (en) 1992-09-28 1993-09-27 Piperidine derivatives their preparation and theirapplication in therapeutics

Country Status (18)

Country Link
US (1) US5418241A (xx)
EP (1) EP0591026A1 (xx)
JP (1) JPH06192254A (xx)
KR (1) KR940007022A (xx)
CN (1) CN1087340A (xx)
AU (1) AU659033B2 (xx)
CA (1) CA2107060A1 (xx)
CZ (1) CZ201493A3 (xx)
FI (1) FI934220A (xx)
FR (1) FR2696176B1 (xx)
HU (2) HUT65396A (xx)
IL (1) IL107132A0 (xx)
MX (1) MX9305930A (xx)
NO (1) NO933434L (xx)
NZ (1) NZ248775A (xx)
PL (1) PL172852B1 (xx)
SK (1) SK103293A3 (xx)
ZA (1) ZA937155B (xx)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2731707B1 (fr) * 1995-03-13 1997-04-30 Synthelabo Derives de benzimidazole, leur preparation et leur application en therapeutique
FR2731708B1 (fr) * 1995-03-13 1997-04-30 Synthelabo Derives de piperidine, leur procede de preparation et leur application en therapeutique
GB9815696D0 (en) * 1998-07-20 1998-09-16 Pfizer Ltd Heterocyclics
GB9818730D0 (en) * 1998-08-27 1998-10-21 Univ Portsmouth Collections of compounds
AU5259100A (en) * 1999-04-28 2000-11-10 Respiratorius Ab Medicament
WO2000076500A2 (en) * 1999-06-15 2000-12-21 Respiratorius Ab Compound for use as a medicament for treatment of disorders involving bronchocontraction
GB9918425D0 (en) * 1999-08-04 1999-10-06 Novartis Ag Organic compounds
ES2256085T3 (es) * 1999-11-23 2006-07-16 Janssen Pharmaceutica N.V. Uso de agonistas de 5ht3 para relajar el fundus.
GB0321295D0 (en) * 2003-09-11 2003-10-15 Spirogen Ltd Synthesis of protected pyrrolobenzodiazepines
PL2270010T3 (pl) * 2004-03-01 2012-07-31 Medimmune Ltd Pochodne 11-hydroksy-5h-pirolo[2,1-c][1,4]benzodiazepin-5-onu jako kluczowe związki pośrednie do otrzymywania c2 podstawionych pirolobenzodiazepin
GB0404577D0 (en) * 2004-03-01 2004-04-07 Spirogen Ltd Pyrrolobenzodiazepines
US7528126B2 (en) * 2004-03-09 2009-05-05 Spirogen Limited Pyrrolobenzodiazepines
NZ563136A (en) * 2005-04-21 2009-11-27 Spirogen Ltd Pyrrolobenzodiazepines
GB0813432D0 (en) * 2008-07-22 2008-08-27 Spirogen Ltd Pyrrolobenzodiazepines
GB0819095D0 (en) * 2008-10-17 2008-11-26 Spirogen Ltd Pyrrolobenzodiazepines
MX2012011900A (es) 2010-04-15 2013-03-21 Seattle Genetics Inc Conjugados de pirrolobenzodiazepina diana.
GB201006340D0 (en) 2010-04-15 2010-06-02 Spirogen Ltd Synthesis method and intermediates
NZ602933A (en) 2010-04-15 2014-09-26 Seattle Genetics Inc Pyrrolobenzodiazepines used to treat proliferative diseases
CN103987718A (zh) 2011-09-20 2014-08-13 斯皮罗根有限公司 作为非对称二聚体pbd化合物用于内含在靶向结合物中的吡咯并苯并二氮杂卓
US9388187B2 (en) 2011-10-14 2016-07-12 Medimmune Limited Pyrrolobenzodiazepines
WO2013053872A1 (en) 2011-10-14 2013-04-18 Spirogen Sàrl Synthesis method and intermediates useful in the preparation of pyrrolobenzodiazepines
US9526798B2 (en) 2011-10-14 2016-12-27 Seattle Genetics, Inc. Pyrrolobenzodiazepines and targeted conjugates
KR101961976B1 (ko) 2011-10-14 2019-03-25 시애틀 지네틱스, 인크. 피롤로벤조디아제핀 및 표적 접합체
CN103998450B (zh) 2011-10-14 2017-03-08 麦迪穆有限责任公司 吡咯并苯并二氮杂卓
WO2014057120A1 (en) 2012-10-12 2014-04-17 Adc Therapeutics Sàrl Pyrrolobenzodiazepine-antibody conjugates
MX364329B (es) 2012-10-12 2019-04-23 Medimmune Ltd Conjugados del anticuerpo pirrolobenzodiazepina.
NZ745069A (en) 2012-10-12 2019-05-31 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
JP6367204B2 (ja) 2012-10-12 2018-08-01 メドイミューン・リミテッドMedImmune Limited 結合用のピロロベンゾジアゼピン誘導体の合成および中間体
US10736903B2 (en) 2012-10-12 2020-08-11 Medimmune Limited Pyrrolobenzodiazepine-anti-PSMA antibody conjugates
SI2906296T1 (en) 2012-10-12 2018-06-29 Adc Therapeutics Sa Pyrrolobenzodiazepine-antibody conjugates
MX364326B (es) 2012-10-12 2019-04-23 Medimmune Ltd Conjugados del anticuerpo pirrolobenzodiazepina - anti-psma.
JP5993093B2 (ja) 2012-10-12 2016-09-14 メドイミューン・リミテッドMedImmune Limited ピロロベンゾジアゼピン類およびその複合体
PT2906251T (pt) 2012-10-12 2017-12-04 Medimmune Ltd Conjugados de pirrolobenzodiazepina-anticorpo anti-cd22
US9956299B2 (en) 2013-10-11 2018-05-01 Medimmune Limited Pyrrolobenzodiazepine—antibody conjugates
GB201317981D0 (en) 2013-10-11 2013-11-27 Spirogen Sarl Pyrrolobenzodiazepines and conjugates thereof
US10010624B2 (en) 2013-10-11 2018-07-03 Medimmune Limited Pyrrolobenzodiazepine-antibody conjugates
EP3054985B1 (en) 2013-10-11 2018-12-26 Medimmune Limited Pyrrolobenzodiazepine-antibody conjugates
GB201317982D0 (en) 2013-10-11 2013-11-27 Spirogen Sarl Pyrrolobenzodiazepines and conjugates thereof
GB201416112D0 (en) 2014-09-12 2014-10-29 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
CA2968447A1 (en) 2014-11-25 2016-06-02 Adc Therapeutics Sa Pyrrolobenzodiazepine-antibody conjugates and their use to treat neoplasms
GB201506402D0 (en) 2015-04-15 2015-05-27 Berkel Patricius H C Van And Howard Philip W Site-specific antibody-drug conjugates
GB201506411D0 (en) 2015-04-15 2015-05-27 Bergenbio As Humanized anti-axl antibodies
GB201601431D0 (en) 2016-01-26 2016-03-09 Medimmune Ltd Pyrrolobenzodiazepines
GB201602359D0 (en) 2016-02-10 2016-03-23 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201602356D0 (en) 2016-02-10 2016-03-23 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201607478D0 (en) 2016-04-29 2016-06-15 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201617466D0 (en) 2016-10-14 2016-11-30 Medimmune Ltd Pyrrolobenzodiazepine conjugates
DK3544636T3 (da) 2017-02-08 2021-05-10 Adc Therapeutics Sa Pyrrolobenzodiazepin-antistof-konjugater
GB201702031D0 (en) 2017-02-08 2017-03-22 Medlmmune Ltd Pyrrolobenzodiazepine-antibody conjugates
RS63502B1 (sr) 2017-04-18 2022-09-30 Medimmune Ltd Konjugati pirolobenzodiazepina
CA3057748A1 (en) 2017-04-20 2018-10-25 Adc Therapeutics Sa Combination therapy with an anti-axl antibody-drug conjugate
UA127900C2 (uk) 2017-06-14 2024-02-07 Ейдісі Терапьютікс Са Схема дозування для введення adc до cd19
WO2019034764A1 (en) 2017-08-18 2019-02-21 Medimmune Limited CONJUGATES OF PYRROLOBENZODIAZEPINE
GB201803342D0 (en) 2018-03-01 2018-04-18 Medimmune Ltd Methods
GB201806022D0 (en) 2018-04-12 2018-05-30 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2579596B1 (fr) * 1985-03-26 1987-11-20 Inst Nat Sante Rech Med (imidazolyl-4) piperidines, leur preparation et leur application en therapeutique
US5008390A (en) * 1985-05-23 1991-04-16 Smithkline Beckman Corporation Compounds for preparing 6-phenyl-2,3-dihydroimidazo[2,1-b]-thiazoles and corresponding thiazines
FR2618435B1 (fr) * 1987-07-23 1989-10-27 Synthelabo Derives de benzimidazole, leur preparation et leur application en therapeutique
IT1230703B (it) * 1989-01-26 1991-10-29 Luso Farmaco Inst Derivati imidazolonici ad attivita' antiipertensiva, loro metodi di preparazione e composizioni farmaceutiche che li contengono.
FR2658823B1 (fr) * 1990-02-27 1992-04-30 Adir Nouveaux derives d'aminomethylpiperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent .
FR2671083B1 (fr) * 1990-12-31 1994-12-23 Inst Nat Sante Rech Med Nouvelles 4-(4-imidazolyl) piperidines substituees en 1, leur preparation ainsi que leurs applications therapeutiques.
FR2674855B1 (fr) * 1991-04-03 1994-01-14 Synthelabo Derives de piperidine, leur preparation et leur application en therapeutique.

Also Published As

Publication number Publication date
AU659033B2 (en) 1995-05-04
FI934220A (fi) 1994-03-29
NO933434D0 (no) 1993-09-27
CA2107060A1 (en) 1994-03-29
MX9305930A (es) 1994-06-30
HUT65396A (en) 1994-06-28
IL107132A0 (en) 1993-12-28
PL172852B1 (pl) 1997-12-31
FR2696176B1 (fr) 1994-11-10
NZ248775A (en) 1995-02-24
US5418241A (en) 1995-05-23
SK103293A3 (en) 1994-08-10
HU9302726D0 (en) 1993-12-28
FR2696176A1 (fr) 1994-04-01
HU211490A9 (en) 1995-11-28
FI934220A0 (fi) 1993-09-27
CZ201493A3 (en) 1994-04-13
KR940007022A (ko) 1994-04-26
JPH06192254A (ja) 1994-07-12
AU4860593A (en) 1994-04-14
CN1087340A (zh) 1994-06-01
NO933434L (no) 1994-03-29
PL300514A1 (en) 1994-04-05
EP0591026A1 (fr) 1994-04-06

Similar Documents

Publication Publication Date Title
ZA937155B (en) Piperidine derivatives their preparation and theirapplication in therapeutics
IL101865A0 (en) Thiopyranopyrrole derivatives and their preparation
ZA93958B (en) Piperazine and piperidine derivatives and their use in therapy
IL111148A0 (en) Imidazol-4- ylpiperidine derivatives, their preparation and their application in therapeutics
IL101222A0 (en) Cyclohexanetriol derivatives and their preparation
IL117455A0 (en) Piperidine derivatives process for the preparation thereof and application thereof in therapeutics
GB9109435D0 (en) Improvements in and relating to cookers
GB9123820D0 (en) Improvements in and relating to locks
ZA937156B (en) Piperidine derivatives their preparation and theirapplication in therapy
ZA943649B (en) Piperidine derivatives their preparation and use
IL92682A0 (en) Piperidinedione derivatives and their reduction to 4-phenylpiperidines
GB2262601B (en) Improvements in and relating to cookers
ZA898480B (en) Phenyloxypropanolamine derivatives,their preparation and their application in therapeutics
GB2221464B (en) Oxaza heterocycles and their use in pharmaceutical compositions
GB9119451D0 (en) Improvements in and relating to transformers
ZA941532B (en) Novel 2-}henoxyethylamine derivatives their preparation and their application in therapeutics
AU1858692A (en) 2-piperidinylpyrimidine-4-carboxamide derivatives, their preparation and their use in therapeutics
GB2262294B (en) Improvements in and relating to grandstands
GB9112545D0 (en) Improvements in and relating to hinges
GB9107448D0 (en) Improvements in and relating to container assemblies
ZA967558B (en) Alpha-phenylpiperidine-1-propanol derivatives their preparation and their application in therapeutics
ZA985727B (en) (1H-imidazol-4-YL) piperidine derivatives their preparation and their application in therapeutics
GB2259322B (en) Improvements in and relating to windows
IL103488A0 (en) Polychlorodipyrido-imidazolium compounds and their use in the preparation of pentachloropyridine
ZA924783B (en) 2-piperidinylpyrimidine-4-carboxamide derivatives,their preparation and their use in therapeutics